TürkçeTurkey is home to some of the world’s leading prostate cancer specialists thanks to its exceptional healthcare ecosystem, which combines outstanding surgical expertise with innovative medical technologies and a patient-centered approach to care. One of the main reasons patients from around the world choose Turkey for treatment is the ability to access personalized oncological solutions without lengthy waiting lists. Highly transparent management of medical processes, uninterrupted communication, and modern recovery environments are critical factors that directly support physicians’ clinical success. This strong ecosystem of trust, built by internationally respected specialists, focuses not only on physical health but also on psychological recovery, continually raising international healthcare standards.
Why Do Prostate Cancer Specialists in Turkey Achieve Global Success?
To understand the foundation of this overall success in prostate cancer treatment, it is useful to examine the international academic training pathways followed by specialists. One of the most important indicators of the international competence of urologists in Turkey is compliance with the standards established by the European Board of Urology. Meeting these standards and obtaining the relevant certifications require extensive professional knowledge and clinical experience. However, passing the examination once is not considered sufficient; maintaining up-to-date medical knowledge is equally important.
As the medical field evolves, new research is published and new treatment protocols are developed every day. Therefore, specialists are expected to regularly provide evidence of continuing medical education through internationally recognized medical education databases based on a structured credit system. The greatest advantage of this system for patients is the assurance that their physician practices according to the most current scientific evidence rather than relying on outdated knowledge. Furthermore, Turkey’s large number of healthcare institutions accredited by Joint Commission International (JCI), one of the world’s most respected indicators of patient safety and healthcare quality, provides a strong institutional foundation for this international success.
Which Methods Are Used for Prostate Cancer Screening and Diagnosis?
Global data show that prostate cancer is one of the most common health problems affecting men. However, this should not be a cause for hopelessness because when the disease is detected while still confined to the prostate gland, maintaining patients’ quality of life and enabling them to live long and healthy lives is often achievable. Early diagnosis is the most critical step in the treatment process. Medical guidelines recommend that individuals with a family history of prostate cancer begin regular evaluations at age 45, while those without additional risk factors should start at age 50.
The screening process generally includes measuring the blood level of a protein called Prostate-Specific Antigen (PSA) and performing a physical examination. However, a common misconception exists within society. Having PSA levels within the normal reference range does not necessarily eliminate the possibility of prostate cancer. In some cases, cellular changes may have already begun despite normal blood test results. Therefore, although blood tests and physical examinations provide valuable clues, they cannot be used as definitive diagnostic tools on their own.
The primary tools commonly used during clinical evaluation include:
- Blood tests
- Physical examination
- Imaging studies
- Tissue biopsy
Why Can Traditional Biopsy Methods Be Insufficient for Diagnosing Prostate Cancer?
When suspicious findings are detected during blood tests or physical examination, the most commonly used method for many years has been the standard ultrasound-guided biopsy performed through the rectum. During this procedure, ultrasound imaging is used to visualize the prostate, and multiple tissue samples are collected. However, current medical approaches have demonstrated that this technique has certain limitations and risks.
First, standard ultrasound images generally do not provide sufficient detail to clearly distinguish cancerous tissue at the cellular level. Consequently, tissue samples are collected according to a random sampling pattern. If suspicious cancer cells are located in the anterior or far peripheral regions of the prostate, the biopsy needle may fail to reach these areas, increasing the likelihood that the disease will be missed. A second and even more important concern involves the biopsy route itself. Since the biopsy needle must pass through the rectal wall, it traverses an area naturally containing a dense bacterial population. As the needle passes through this environment, bacteria may be transferred into the prostate tissue or bloodstream, increasing the risk of post-procedural infections.
What Advantages Does Transperineal MRI-TRUS Fusion Biopsy Offer in the Diagnosis of Prostate Cancer?
To overcome the limitations associated with traditional methods, modern medicine has integrated advanced imaging technologies into the biopsy process. This new approach begins with high-resolution Magnetic Resonance Imaging (MRI). Radiologists analyze these images, identify differences in tissue density, and mark suspicious areas using specialized software. During the biopsy, real-time ultrasound images are then combined three-dimensionally with the previously marked MRI images on a computer screen.
This process is called image fusion. By superimposing the images, the physician no longer has to search blindly but instead can directly target the suspicious area identified by the computer. The “transperineal” aspect of the procedure refers to inserting the biopsy needles through the sterilized skin between the anus and the scrotum (the perineum), rather than through the rectum. This approach significantly minimizes contact with intestinal bacteria, thereby substantially reducing the risk of infection after the procedure. It also provides easier and more accurate access to regions that are technically difficult to reach through the rectal route.
What Role Does Robotic Radical Prostatectomy Play in the Treatment of Prostate Cancer?
If detailed evaluations confirm the presence of cancer within the prostate gland, various treatment plans are developed based on the extent of the disease and the patient’s overall health. In patients who are suitable surgical candidates, removal of the prostate gland and, in some cases, certain surrounding structures remains one of the primary treatment approaches. Robotic surgical systems, among the most significant technological advances in modern medicine, enable these procedures to be performed with much greater precision and control.
Robotic systems are not autonomous machines that perform surgery independently; rather, they are advanced interfaces that translate the surgeon’s hand movements into highly precise movements within the surgical field. During the operation, the surgeon sits at a console beside the patient and views the tissues in three-dimensional, high-definition, magnified detail. The robotic instruments possess a range of motion and flexibility far beyond that of the human hand. Additionally, the system filters out even the smallest physiological tremors of the surgeon’s hands. This level of visualization and maneuverability is especially valuable within the confined anatomy of the pelvis, allowing removal of diseased tissue while minimizing injury to surrounding healthy structures.
What Are the Trifecta Success Criteria in Prostate Cancer Surgery?
When prostate surgery becomes necessary, patients naturally have several major concerns. These include whether all of the cancer will be removed, whether urinary control will be preserved, and whether sexual function will be affected. Successful surgery aims not only to remove cancerous tissue but also to preserve the patient’s quality of life afterward. In medical terminology, this approach is referred to as the “Trifecta,” representing the simultaneous achievement of three essential goals.
The first goal is obtaining oncologically negative surgical margins. The second is preserving the integrity of the urinary sphincter muscle located just below the prostate, which controls urine flow like a valve. Careful preservation of this muscle helps patients maintain normal urinary continence following surgery. The third objective is protecting the delicate nerve bundles running along both sides of the prostate that are responsible for erectile function.
The three primary objectives are:
- Complete removal of cancer cells
- Preservation of urinary control muscles
- Preservation of the nerves responsible for sexual function
How Does the Surgeon’s Experience Influence Prostate Cancer Surgery?
Although robotic technology is highly advanced, the surgeon’s knowledge and operative experience remain among the most important factors influencing surgical outcomes. Robotic systems do not provide tactile feedback, meaning the surgeon cannot physically feel the tissues being manipulated. Instead, tissue consistency, tension, and anatomical characteristics must be interpreted entirely through visual information displayed on the monitor. Accurately interpreting these visual cues is a skill that develops through extensive experience.
Clinical observations and research have shown that surgical teams performing these procedures regularly become significantly more efficient during the most technically demanding stages of the operation. Greater efficiency does not mean rushing but rather reflects mastery of anatomy and greater precision in surgical maneuvers. Shorter procedures reduce the duration of anesthesia exposure and contribute to faster tissue healing. An experienced surgical approach also improves the quality of the reconstruction connecting the bladder and urethra, potentially shortening catheterization time and allowing patients to return to normal daily activities sooner.
What Options Do Focal Therapy Strategies Offer in the Management of Prostate Cancer?
In the past, treatment for prostate cancer generally involved treating the entire prostate gland whenever cancer cells were detected. Today, however, more localized approaches have been developed according to the biological characteristics of the disease and individual patient expectations. If the tumor is not highly aggressive, has not spread, and remains confined to a single region of the prostate, treatment directed solely at the affected area may be considered, similar to approaches used for certain other cancers. These techniques are known as focal therapies.
The fundamental concept behind focal therapy is to control the disease while minimizing potential effects on the critical nerves and urinary structures surrounding the prostate. Treating only the diseased area instead of the entire organ significantly reduces the likelihood of side effects that may negatively affect quality of life.
The primary focal ablation techniques include:
- High-Intensity Focused Ultrasound
- Cryotherapy
- Laser ablation
- Irreversible electroporation
How Does High-Intensity Focused Ultrasound (HIFU) Work in Prostate Cancer?
Among focal treatment options, High-Intensity Focused Ultrasound (HIFU) has accumulated one of the largest bodies of scientific evidence. Its working principle may be compared to using a magnifying glass to focus sunlight onto a single point to generate heat. From the outside, no surgical incision is made.
During the procedure, a specialized probe is inserted using an appropriate route and generates high-frequency sound waves. These sound waves are directed precisely toward the tumor within the prostate. As they pass through surrounding tissues, they cause no damage. However, at the focal point where they converge within the tumor, they generate extremely high temperatures within a very short period. This sudden rise in temperature destroys the structure of cancer cells while sparing surrounding healthy tissue. Modern HIFU systems operate using computer software and robotic guidance. The physician identifies the treatment area using previously acquired MRI images, and the system precisely confines the ultrasound energy within those predefined boundaries, ensuring that heat remains restricted to the target tissue.
Which Patients Are Suitable Candidates for Focal Prostate Cancer Treatments?
Although innovative and minimally invasive, focal treatments such as HIFU and cryotherapy are not appropriate for every patient. Achieving the desired clinical outcomes requires careful patient selection according to specific medical criteria. Applying localized treatment to an unsuitable patient may allow the disease to progress; therefore, selection must be extremely meticulous.
First, the disease should generally be in its early stages. Pathological evaluation should indicate low- or intermediate-grade cancer cells. In addition, advanced MRI should demonstrate that the disease is confined to a single lesion or a dominant tumor focus rather than being scattered throughout the prostate. Furthermore, patients who previously received radiation therapy and later develop localized recurrence in the same region may be good candidates for salvage focal therapies, as undergoing another major surgical procedure may be particularly challenging.
The patient profile generally considered suitable includes:
- Early-stage disease
- Low- or intermediate-grade cancer cells
- A tumor confined to a single focal area
- Laboratory values below specified thresholds
How Are Prostate Cancer Diagnosis and Treatment Decisions Planned Through a Multidisciplinary Approach?
Modern medicine emphasizes that complex diseases should be managed through collaboration among specialists rather than relying on a single physician’s opinion. At advanced centers in Turkey, patients diagnosed with prostate cancer are discussed extensively during multidisciplinary tumor board meetings. These meetings bring together urologists, radiologists, medical oncologists, radiation oncologists, and pathologists to review each patient’s case comprehensively.
The patient’s age, overall health, coexisting medical conditions, and personal expectations are evaluated as a whole. For example, when a very low-risk tumor expected to progress slowly is identified, physicians often recommend an active surveillance program instead of immediately initiating aggressive treatment. Active surveillance does not mean ignoring the disease; rather, it involves closely monitoring the patient through regular blood tests and imaging studies. If signs of progression appear during follow-up, appropriate treatment is initiated promptly. For more advanced cases, comprehensive multimodal treatment plans combining surgery, hormone therapy, and radiotherapy are generally developed.
Which Foods Should Be Consumed to Help Prevent Prostate Cancer or Slow Its Progression?
Maintaining prostate health or supporting disease control after diagnosis is not limited to medical treatment alone. Lifestyle habits and daily dietary choices may exert important effects at the cellular level. Scientific evidence suggests that certain naturally occurring compounds may have protective and beneficial effects on prostate cells.
In particular, lycopene, the antioxidant responsible for the red color of tomatoes, is considered especially valuable for prostate health. Interestingly, the body’s absorption of lycopene increases when tomatoes are cooked or gently heated. Therefore, tomato paste and natural tomato products are considered excellent dietary sources. In addition, powerful antioxidant compounds found in green tea and phytoestrogen-rich foods such as soybeans contribute significantly to maintaining healthy cellular function. Adopting a Mediterranean-style diet rich in vegetables is consistently beneficial for overall health.
Foods generally recommended for inclusion in the diet include:
- Cooked tomatoes
- Green tea
- Soy products
- Marine fish
- Leafy green vegetables
Which Foods and Habits Should Be Avoided to Reduce the Risk of Prostate Cancer?
In addition to protective foods, certain dietary habits may increase inflammation within the body and promote abnormal cellular growth. In particular, diets rich in animal fats and excessive red meat consumption are generally considered unfavorable for prostate health. Clinical observations suggest that certain fatty acids present in red meat may accelerate existing cellular abnormalities.
Another highly important factor is body weight. Excess body fat is not merely an energy storage site but functions as an active organ that continuously releases various hormones and growth factors into the bloodstream. Substances such as leptin, secreted by fat cells, are believed to increase signals that promote uncontrolled cellular growth. Therefore, maintaining a healthy body weight through balanced nutrition and regular physical activity represents an important strategy for slowing disease progression.
Foods and substances generally recommended to be limited or avoided include:
- Red meat
- Animal fats
- Processed deli meats
- High-calorie foods
- Sugary beverages
In summary, managing prostate cancer within technologically advanced centers that embrace a multidisciplinary approach represents one of the safest pathways for patients. Proper treatment planning performed by experienced specialists plays a significant role in preserving quality of life and supporting a healthier future. This extensive medical knowledge and clinical experience continue to help patients complete their treatment journey with greater comfort and confidence. Supporting medical treatment through appropriate lifestyle modifications remains one of the most valuable complementary approaches.
Frequently Asked Questions
